Format

Send to

Choose Destination
See comment in PubMed Commons below
Leukemia. 2013 Aug;27(8):1789-91. doi: 10.1038/leu.2013.61. Epub 2013 Feb 28.

Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: produces stable disease but at the cost of high toxicity.

PMID:
23446311
DOI:
10.1038/leu.2013.61
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center